276 filings
Page 4 of 14
CORRESP
v9t2v41neivq8y8fz
23 May 18
Correspondence with SEC
12:00am
8-K
gvssx9ae 3v8i88b
15 May 18
Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update
8:30am
424B5
r5eu8pi
15 May 18
Prospectus supplement for primary offering
8:14am
DEFA14A
vmvqgsdba6nv e69d26
15 May 18
Additional proxy soliciting materials
8:11am
DEFR14A
wro886r
1 May 18
Revised proxy
12:00am
DEFA14A
vdy yn4f4lrgblvm6uog
27 Apr 18
Additional proxy soliciting materials
4:02pm
8-K
2qog cd1p10
21 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
w5d9ma8 ejv0x
13 Mar 18
Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
12:00am
8-K
k7jqkwu6ax0cio
6 Mar 18
Departure of Directors or Certain Officers
12:00am
424B3
pmehju0yzjwraz
5 Jan 18
Prospectus supplement
12:00am
EFFECT
j4r9bjv54l35lpwokpr
4 Jan 18
Notice of effectiveness
12:00am
CORRESP
flsplll9dq39a 8ih66e
2 Jan 18
Correspondence with SEC
12:00am
CORRESP
v9x0l
28 Dec 17
Correspondence with SEC
12:00am
UPLOAD
kna065 frjs
20 Dec 17
Letter from SEC
12:00am